Xeris Biopharma Holdings, Inc. XERS

9.10 0.15 1.68% as of 25 Sep
Market cap
$1.6B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
240.31 167.66 156.26 186.82 142.60 152.21 87.48 117.90 44.05 33.17
Total non-current assets
143.21 155.40 166.34 157.70 161.77 6.94 21.50 2.13 0.95 0.36
Total Assets
383.53 323.06 322.60 344.52 304.36 159.15 108.99 120.03 45.00 33.53
Total current liabilities
109.57 100.44 95.19 73.62 79.04 28.21 27.34 10.17 4.86 2.53
Total non-current liabilities
260.26 252.23 234.19 225.71 130.09 97.18 67.21 34.45 0.09 0.04
Total liabilities
369.84 352.68 329.38 299.34 209.13 125.39 94.55 44.62 4.95 2.57
Common Equity (Total)
13.69 (29.61) (6.78) 45.19 95.23 33.76 14.44 75.41 (57.83) (31.93)
Shareholders Equity (Total)
13.69 (29.61) (6.78) 45.19 95.23 33.76 14.44 75.41 40.05 30.96
Total Debt
220.34 232.11 190.93 188.66 88.07 87.02 58.31 31.89 — —

Show all line items

In millions of $ except per-share values · columns are period end dates